Nicholas Investment Partners, LP Verona Pharma PLC Transaction History

Nicholas Investment Partners, LP

  • $900 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
SELL
$11.94 - $20.47 $11.9 Million - $20.3 Million
-993,863 Reduced 85.46%
169,126 $3.36 Million
Q3 2023

Nov 13, 2023
SELL
$16.3 - $22.09 $5,965 - $8,084
-366 Reduced 0.03%
1,162,989 $19 Million
Q2 2023

Aug 09, 2023
BUY
$19.41 - $23.43 $4.31 Million - $5.2 Million
222,055 Added 23.59%
1,163,355 $24.6 Million
Q1 2023

May 11, 2023
BUY
$18.06 - $25.27 $17 Million - $23.8 Million
941,300 New
941,300 $18.9 Million

Others Institutions Holding VRNA

# of Institutions
166
Shares Held
68.7M
Call Options Held
704K
Put Options Held
685K
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.17B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email